| 1 |
35262460 | VEGF single nucleotide polymorphisms predict improved outcome in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. | 2022 Mar 9 |
2 |
| 2 |
35405577 | HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma. | 2022 May |
3 |
| 3 |
33423551 | Oregovomab: an investigational agent for the treatment of advanced ovarian cancer. | 2021 Feb |
2 |
| 4 |
33932471 | Platinum-based chemotherapy and bevacizumab instigate the destruction of human ovarian cancers via different signaling pathways. | 2021 Jun |
2 |
| 5 |
34083285 | Calcitriol Combined With Platinum-based Chemotherapy Suppresses Growth and Expression of Vascular Endothelial Growth Factor of SKOV-3 Ovarian Cancer Cells. | 2021 Jun |
1 |
| 6 |
34465291 | Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma. | 2021 Aug 31 |
1 |
| 7 |
32279102 | Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine. | 2020 May |
1 |
| 8 |
29631257 | Anti-Angiogenics: Their Value in Lung Cancer Therapy. | 2018 |
2 |
| 9 |
30306576 | Targeted therapy for gynecologic cancers: Toward the era of precision medicine. | 2018 Oct |
1 |
| 10 |
28176920 | Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer. | 2017 |
5 |
| 11 |
29129443 | Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial. | 2017 Dec |
1 |
| 12 |
26619847 | Does the addition of drugs targeting the vascular endothelial growth factor pathway to first-line chemotherapy increase complete response? A meta-analysis of randomized clinical trials. | 2016 May |
1 |
| 13 |
27460845 | ACE2 overexpression inhibits acquired platinum resistance-induced tumor angiogenesis in NSCLC. | 2016 Sep |
1 |
| 14 |
26143638 | Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer. | 2015 Sep 29 |
1 |
| 15 |
26675567 | Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives. | 2015 |
1 |
| 16 |
24850841 | VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy. | 2014 Jul 15 |
1 |
| 17 |
23199019 | Aflibercept in lung cancer. | 2013 Jan |
1 |
| 18 |
24090479 | Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. | 2013 Dec |
1 |
| 19 |
21221762 | Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer. | 2011 May |
5 |
| 20 |
21964533 | Phase II study of cediranib in patients with malignant pleural mesothelioma: SWOG S0509. | 2011 Nov |
1 |
| 21 |
20593550 | A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung. | 2010 Jul |
1 |
| 22 |
18036640 | Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy. | 2008 Feb |
1 |
| 23 |
17594186 | Broadening the clinical use of platinum drug-based chemotherapy with new analogues. Satraplatin and picoplatin. | 2007 Jul |
1 |
| 24 |
16764755 | Angiogenesis inhibitors in lung cancer: a promise fulfilled. | 2006 May |
1 |
| 25 |
15253542 | Vascular endothelial growth factor immobilized on platinum microcoils for the treatment of intracranial aneurysms: experimental rat model study. | 2004 Jun |
2 |
| 26 |
11498439 | Delivery of human vascular endothelial growth factor with platinum coils enhances wall thickening and coil impregnation in a rat aneurysm model. | 2001 Aug |
1 |